U.S. Markets closed
  • S&P Futures

    4,333.75
    -7.75 (-0.18%)
     
  • Dow Futures

    33,959.00
    -96.00 (-0.28%)
     
  • Nasdaq Futures

    14,156.75
    -1.75 (-0.01%)
     
  • Russell 2000 Futures

    1,960.30
    -12.40 (-0.63%)
     
  • Crude Oil

    87.12
    -0.23 (-0.26%)
     
  • Gold

    1,820.10
    -9.60 (-0.52%)
     
  • Silver

    23.59
    -0.22 (-0.91%)
     
  • EUR/USD

    1.1236
    -0.0009 (-0.0787%)
     
  • 10-Yr Bond

    1.8480
    +0.0650 (+3.65%)
     
  • Vix

    31.96
    +0.80 (+2.57%)
     
  • GBP/USD

    1.3448
    -0.0015 (-0.1089%)
     
  • USD/JPY

    114.6600
    0.0000 (0.0000%)
     
  • BTC-USD

    36,975.28
    +227.48 (+0.62%)
     
  • CMC Crypto 200

    843.61
    -12.20 (-1.43%)
     
  • FTSE 100

    7,469.78
    +98.32 (+1.33%)
     
  • Nikkei 225

    26,960.16
    -51.17 (-0.19%)
     

CNO Financial (CNO) Up 48% in 6 Months: More Room to Run?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • CNO

CNO Financial Group, Inc. CNO has been gaining momentum from producing low risk products, and pursuing an integrated care delivery approach and constant technology upgradations. The company has beat estimates in the trailing four quarters.

Shares of the multiline insurer have gained 48.1% in the past six months compared with the industry and the Finance sector’s rally of 26.7% and 23.6%, respectively. The Zacks S&P 500 composite has risen 18.9% in the said time frame. With market capitalization of $3.3 billion, average volume of shares traded in the last three months was 0.9 million.

The company has an impressive Value Score of A, which reflects an attractive valuation of the stock.

Will the Bull Run Continue?

This Zacks Rank #3 (Hold) insurer is poised to benefit from a well-diversified product portfolio comprising life, fixed annuities, Medicare supplement, supplemental health and limited benefit duration long-term care (LTC). The products usually bear low risk and provide assurance of addressing the insurance needs of American middle market. A diversified portfolio also equips the company to manage risks effectively.

CNO Financial continues to roll out solutions for customers devoid of a financial product in the senior middle market, which has reinforced customers’ belief on the company. The solutions primarily strive to grow the asset value of clients and simultaneously take care of their escalating healthcare costs as they attain the age of retirement.

Moreover, CNO Financial has been pursuing a transformation strategy, wherein the company has started following an integrated care delivery model. The model brings protection, retirement planning and asset growth solutions under a single platform, which has paved the way for an omni-channel buying experience for its customers.

The company’s cost-control efforts have also started bearing fruits as operating expenses have started witnessing a downtrend from 2019. It has been making substantial investments in technology so that customers can opt for digital means while buying the company’s products.

Additionally, CNO Financial boasts a strong capital position. Though it has been following a conservative capital structure amid the pandemic, the company plans to pursue growth initiatives for bolstering product offerings and distribution network and undertake share repurchases as per market conditions. It targets leverage ratio between 22.5-25%. Also, the company has solid cash generation abilities.

Stocks to Consider

Some better-ranked stocks in the insurance space are Kemper Corporation KMPR, Manulife Financial Corporation MFC and Primerica, Inc. PRI, each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Kemper, Manulife Financial and Primerica have a trailing four-quarter earnings surprise of 24.01%, 6.87% and 10.04%, on average, respectively.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CNO Financial Group, Inc. (CNO) : Free Stock Analysis Report
 
Manulife Financial Corp (MFC) : Free Stock Analysis Report
 
Kemper Corporation (KMPR) : Free Stock Analysis Report
 
Primerica, Inc. (PRI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research